Jeffrey Erickson

Jeffrey Erickson

Company: Triumvira Immunologics Inc

Job title: Vice President, Business Development

Seminars:

Next-Generation Cell Therapies Targeting Claudin: Overcoming Challenges & Improving Outcomes 12:00 pm

Showcasing the latest advancements in next-generation cell therapies targeting claudin, emphasizing novel approaches beyond CAR-T Understanding improvements in toxicity profiles and the durability of therapeutic responses in solid tumors Highlighting early clinical data and preclinical insights to illustrate the effectiveness and potential of these innovative therapiesRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.